Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis?
- PMID: 1291857
Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis?
Abstract
Primary hyperparathyroidism (PHP) might be characterized by either prevailing bone or renal stone patterns with different metabolic features. To explore the possibility of different hormonal patterns we studied 129 patients with PHP: 95 stone formers (SF) and 34 nonstone formers (NSF). Females prevailed over males in both groups. Severe and specific bone lesions were more evident in NSF than SF. Parathyroid gland histology displayed a prevalence of adenoma in NSF, whereas isolated hyperplasia prevailed in SF. SF had lower levels of serum Ca, urinary Ca, ALP and serum PTH than NSF. As expected serum 1,25-dihydroxyvitamin D [1,25(OH)2 D] levels were greater in both groups of patients than in controls but we found no difference between the two groups. 25-Hydroxyvitamin D was neither increased with respect to controls nor different between groups. We conclude that patients with PHP may represent well separated metabolic and clinical entities, but we cannot confirm that serum 1,25(OH)2D levels play a key role in discriminating the different clinical features. In addition, the findings of predominant parathyroid hyperplasia in SF and the clinical evidence of recurrent hyperparathyroidism only in these patients suggest the possibility that the endocrine disorder might be the consequence over time rather than the cause of nephrolithiasis.
Similar articles
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism.Bone Miner. 1986 Apr;1(2):137-44. Bone Miner. 1986. PMID: 3508721
-
Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism?Miner Electrolyte Metab. 1996;22(4):203-6. Miner Electrolyte Metab. 1996. PMID: 8807622
-
[Nephrolithiasis and bone involvement in primary hyperparathyroidism. The relative role of vitamin D].Rev Clin Esp. 1992 Mar;190(5):238-42. Rev Clin Esp. 1992. PMID: 1579694 Spanish.
-
[Review of the concept of vitamin D "sufficiency and insufficiency"].Nefrologia. 2003;23 Suppl 2:73-7. Nefrologia. 2003. PMID: 12778859 Review. Spanish.
Cited by
-
The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption.J Endocrinol Invest. 1996 Jan;19(1):12-20. doi: 10.1007/BF03347852. J Endocrinol Invest. 1996. PMID: 8851686 Clinical Trial.
-
Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.Endocrine. 2017 Jan;55(1):256-265. doi: 10.1007/s12020-016-0931-8. Epub 2016 Mar 31. Endocrine. 2017. PMID: 27033542
-
Hypercalcemic States associated with nephrolithiasis.Rev Urol. 2008 Summer;10(3):218-26. Rev Urol. 2008. PMID: 18836558 Free PMC article.
-
Biochemical characterization of primary hyperparathyroidism with and without kidney stones.Urol Res. 2007 Jun;35(3):123-8. doi: 10.1007/s00240-007-0096-2. Epub 2007 May 3. Urol Res. 2007. PMID: 17476495
-
Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study.BMJ. 2002 Oct 12;325(7368):807. doi: 10.1136/bmj.325.7368.807. BMJ. 2002. PMID: 12376441 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials